Skip to content

Thymalin

Human clinical Immune Support In 1 protocol 3 sources

Thymalin is a thymus-derived polypeptide complex that acts as a broad-spectrum immunomodulator. Research indicates it supports immune function by regulating T-cell differentiation and proliferation, and it has been studied for its potential in treating immunodeficiencies, respiratory infections, and age-related immune decline.

01Dosing reference

Amount
10 mg per day
Frequency
Once daily for 5-10 days
Cycle
Repeated every 1-6 months depending on immune status
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Gene expression regulation

Short peptides within the Thymalin complex interact with DNA and histones to regulate the expression of specific genes related to immunity.

02

T-cell modulation

It stimulates the differentiation and proliferation of T-lymphocytes while reducing the apoptosis (programmed cell death) of lymphoid cells.

03

Immune homeostasis

This leads to the restoration of cellular immunity, enhanced phagocytosis, and a normalized ratio of T- and B-lymphocytes in the body.

03Human evidence

Improved immune status in severe COVID-19 patients.

A clinical study demonstrated that Thymalin regulated immune status, reduced lymphopenia, and improved outcomes in patients suffering from severe COVID-19.

Efficacy in acute respiratory diseases and chronic immune dysfunction.

Decades of clinical use and studies in Russia have shown its effectiveness as an immunocorrector in various chronic pathologies and immune dysfunctions.

04Preclinical evidence

Activation of hematopoietic stem cell differentiation.

In vitro studies showed that Thymalin stimulates the differentiation of human hematopoietic stem cells into lymphoid lineages.

Antitumor effects and thymus protection.

Experiments on rats with transplanted tumors showed Thymalin exerted pronounced antitumor effects and protected the thymus gland during chemotherapy.

05What is known vs. unknown

Reasonably established
  • Thymalin is a polypeptide complex originally extracted from the thymus gland of calves.
  • It contains short active peptides (such as KE and EW) that are responsible for its biological activity.
  • It has been used clinically in Russia and Eastern Europe for decades as an immunomodulator.
  • Research shows it can help restore immune function in aging populations and those with chronic infections.
Unknowns & limits
  • There is a lack of large-scale, randomized controlled trials in Western countries, and it is not FDA-approved.
  • The exact synergistic mechanisms of all the individual peptides within the complex are not fully mapped.
  • Long-term safety data in diverse global populations remains limited.

06Safety & regulatory context

Regulatory statusThymalin has a long history of clinical use in Russia and some Eastern European countries for treating immune dysfunction, where it is considered generally safe with a low incidence of side effects. However, it is not approved by the FDA for medical use in the United States and is typically sold as a research chemical. Potential side effects may include localized injection site reactions or mild allergic responses. It should be used with caution in individuals with autoimmune disorders, as stimulating the immune system could theoretically exacerbate these conditions.

07Compared with Thymosin Alpha-1 (TA1)

Thymalin vs. Thymosin Alpha-1 (TA1)
Key difference
Thymalin is a complex of multiple thymus-derived peptides, whereas Thymosin Alpha-1 is a single, specific 28-amino acid peptide.
When researchers discuss each
TA1 is often discussed in the context of targeted viral and cancer therapies with more global recognition, while Thymalin is frequently referenced in Russian literature for broad immunocorrection and geroprotective (anti-aging) protocols.

08Appears in protocols

09Glossary

Immunomodulator
A substance that helps regulate or normalize the immune system.
T-lymphocytes (T-cells)
A type of white blood cell essential for the immune response, particularly in fighting viral infections and cancer.
Apoptosis
Programmed cell death, a normal process that the body uses to clear out old or damaged cells.

10Knowledge check

Q1What is the primary biological action of Thymalin?
Q2How does Thymalin differ from Thymosin Alpha-1?
Q3Which documented limitation in the dossier should most affect how researchers interpret claims about Thymalin’s clinical benefits?
Q4According to the dossier, in which research contexts are Thymalin and Thymosin Alpha-1 (TA1) most often discussed differently?
Q5Which statement accurately reflects the dossier’s safety and regulatory description of Thymalin?

11Sources

More in Immune Support

See all
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.